Atai Beckley N.V.
company.status.inactiveCIK 1840904fmd_017439K9DHNRCYS7663SCVFM4XManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2020 to Sep 30, 2025, 22 periods
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Total revenues | 0 | 20 | 0 | 0 | 0 |
| Research and development | 11 | 48 | 3 | 2 | 0 |
| Total operating expenses | 104 | 156 | 145 | 126 | 103 |
| Compensation and benefits | – | – | 1 | 1 | 1 |
| Operating income | (104) | (136) | (145) | (125) | (103) |
| Interest expense | – | – | 1 | 3 | 3 |
| Interest and investment income | 0 | 0 | 1 | 2 | 1 |
| Other non-operating income (expense) | 2 | (1) | 10 | 86 | (46) |
| Income before taxes | (102) | (137) | (135) | (39) | (148) |
| Income tax expense | 0 | 4 | 6 | 1 | (0) |
| Net income from continuing operations | (102) | (141) | (141) | (40) | (148) |
| Net income | (170) | (168) | (152) | (40) | (149) |
| Net income to common shareholders | – | – | (152) | (40) | (149) |